Expression profiling in APP23 mouse brain: inhibition of Aβ amyloidosis and inflammation in response to LXR agonist treatment
<p>Abstract</p> <p>Background</p> <p>Recent studies demonstrate that in addition to its modulatory effect on APP processing, <it>in vivo </it>application of Liver X Receptor agonist T0901317 (T0) to APP transgenic and non-transgenic mice decreases the level...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-10-01
|
Series: | Molecular Neurodegeneration |
Online Access: | http://www.molecularneurodegeneration.com/content/2/1/20 |